CCL3 and metabolic dysfunction-associated steatohepatitis: As demonstrated by Yi-yun Tan et al. [51], PCP can regulate the NF-κB/CCL3/CCR1 axis, thereby reducing hepatic injury and inflammation in NASH mice.